BSE filing, NSE: YATHARTH. Summary written from the filing by ALFA Finder's alert engine.
Yatharth Hospital & Trauma Care Services Ltd: key numbers
- Share price
- ₹944.00
- Market cap
- ₹9,096 Cr
- Revenue (annual)
- ₹1,207 Cr
- Net profit (annual)
- ₹175.4 Cr
- P/E (TTM)
- 50.2×Sector 51.1×
- Promoter holding
- 55.80%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yatharth Hospital & Trauma Care Services Ltd
All →Yatharth Hospital & Trauma Care Services Board Meeting Date
Yatharth Hospital intimated that its Board will meet on 3 Nov 2026 to consider Q2 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital & Trauma Care Services Ltd announced the voting results for its Extraordinary General Meeting held on October 15, 2026, where all five resolutions passed.
Yatharth Hospital & Trauma Care Services Preferential Issue
Yatharth Hospital's EGM approved increasing authorized share capital, issuing subscription securities (equity shares and warrants) via preferential placement, and amending articles of association.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital & Trauma Care Services issued a corrigendum to the EGM notice dated September 22, 2026, regarding its proposed preferential issue of equity shares and warrants.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital issued an EGM notice for October 15, 2026. Agenda items include a preferential issue and authorized capital increase.
Yatharth Hospital & Trauma Care Services Annual General Meeting
Yatharth Hospital convened an EGM to approve increasing its authorized share capital and a preferential issue of equity shares and warrants aggregating to ₹1,283.33 Crore.
- Value
- ₹1,283 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.